The global increase in ESBL-producing Escherichia coli is associated with the ST131 clonal group, especially its CTX-M-15-producing H30Rx subset. To understand the rapid spread of ESBL-producing E. coli in Japan, we investigated the molecular epidemiology and ESBL-associated genetic environments of Japanese ST131 isolates.
Introduction
The global increase in ESBL-producing Escherichia coli is closely tied to a pandemic clonal group known as ST131, many members of which produce CTX-M-type ESBLs. 1 -3 The ST131 clonal group, a subset within the larger B2 phylogenetic group, is associated primarily with serogroup O25b. 2 -4 Additionally, our regional surveillance programme in Japan 5 and studies from other countries 6 -9 have shown that the global ST131 clonal group also includes an O16 subset, which represents a distinct phylogenetic clade. 5 Members of ST131 are primarily extraintestinal pathogenic E. coli (ExPEC), harbour a greater number of virulence factors than other resistance-associated E. coli 2, 10 and can cause severe infections. 2, 9 A virotyping method has been proposed that may help identify virulent subgroups within ST131 based on virulence gene profiles. 22, H22; 1967-1999) to the ciprofloxacin-resistant H30 subclonal group (H30R subset; 2000 -11) seemed to explain the recent emergence of fluoroquinolone-resistant E. coli. 12 Further studies elucidated that most ESBL-producing MDR ST131 isolates likewise represented the H30R subclonal group. 11, 13, 14 These ST131 H30R isolates often produce CTX-M-15, the most common ESBL worldwide. 1, 2 In addition, the majority of globally distributed CTX-M-15-producing ST131 H30R isolates were encompassed by the H30Rx subclonal group. 15 H30Rx was identified by WGS analysis as a tight clonal subset within the H30R subclonal group. 14, 16 However, in Japan, despite the same predominance of ST131 among ESBL-producing E. coli as noted elsewhere, ESBLproducing ST131 isolates commonly have bla CTX-M- 14 and bla CTX-M-27 rather than the globally prevalent bla CTX-M-15 . 5 bla CTX-M-14 is the second most common ESBL type in the world 1 and is harboured by both ST131 and non-ST131 E. coli. 2, 5, 17, 18 ESBL genes are generally located on plasmids. Diverse types of bla CTX-M -encoding plasmids were found in the ST131 isolates, 10 and even within the highly genetically homogeneous H30Rx group the bla CTX-M-15 mobile element was inserted variably in plasmidic and diverse chromosomal locations. 16 Thus, mobile genetic elements other than (or in addition to) plasmids seem important to understand, as contributors to the spread of ESBL genes among E. coli and other Enterobacteriaceae.
CTX-M genes are usually flanked by ISs, such as ISEcp1 or IS26, within a mobile element. 19 However, data are lacking regarding the bla CTX-M-14 -and bla CTX-M-27 -associated genetic structures and their associations with clonal groups. The distinctive bla CTX-M types prevalent in Japan and the limited data regarding bla CTX-M genetic elements within ST131 urged us to investigate the associations between subclonal groups and ESBL-related mobile elements among Japanese ST131 isolates. Specifically, we sought to define the prevalence of ST131 subclonal groups among Japanese ESBL-producing E. coli and to investigate these subclonal groups' associated bla CTX-M genetic environments, thereby clarifying the epidemiology and mechanisms of spread of ESBL-producing E. coli.
Materials and methods

Bacterial isolates
This study was conducted at 10 acute-care hospitals in the Kyoto and Shiga regions of Japan. The Kyoto and Shiga regions (combined population, 4 million) are adjacent to each other in central Japan. Ten of the 22 acute-care hospitals in these regions that had more than 400 beds and a microbiology laboratory participated in the study. Between April 2001 and December 2012, 18025 non-duplicate E. coli isolates were obtained from clinical specimens. A total of 1141 isolates that tested positive in an ESBL confirmation test 20 that was performed at each hospital were sent to a reference laboratory (Kyoto University) for further investigation. The collection was conducted annually, but the collection period and number of participating hospitals varied between years. Isolates were collected and saved anonymously, without accompanying demographic data. PCR analysis (as described below) identified 1079 ESBL gene-positive isolates, which constituted the present study population. Of these, 581 isolates collected between 2001 and 2010 were previously characterized, 5,10 whereas 498 were newly studied here. For the 62 isolates in which we found no ESBL genes, we re-examined CLSI ESBL screening and confirmatory tests 20 in the reference laboratory to confirm maintenance of the ESBL phenotype despite storage. Upon retesting, one isolate was negative in the ESBL screening test and another 47 isolates were negative in the ESBL confirmatory test, leaving 14 with an unexplained ESBL phenotype.
b-Lactamase identification
Bacterial DNA was isolated using a QIAamp DNA Mini kit (Qiagen, Hilden, Germany). The presence of ESBL or plasmid-mediated AmpC b-lactamase (pAmpC) genes was defined by PCR amplification and sequencing of bla CTX-M , 21 genes and the six main groups of pAmpC-type genes, 28 as described previously. Isolates non-susceptible to imipenem or meropenem (MIC .1 mg/L) were analysed to determine the presence of the carbapenemases encoded by the bla GES , bla OXA-48 -like, bla IMP , bla VIM , bla KPC and bla NDM genes. 25 Detection of ST131 and its subclones ST131 status was defined based on PCR detection of ST131-specific SNPs in mdh and gyrB. 29 This assay specifically detects mdh allele 36 and gyrB allele 47, two of the seven MLST loci that define ST131, which are sufficient alone to determine an isolate's ST131 status. 29 Phylogenetic grouping using Clermont's triplex PCR 30 and O typing using PCR detection of the O25b 31 and O16 32 rfb variants was also performed to confirm the B2-O25b or B2-O16 status of ST131 isolates. In addition to randomly selected B2-O25b and B2-O16 ST131 isolates, putative phylogenetic group B1 or O-non-typeable ST131 isolates underwent full MLST using the Achtman scheme 5 (http://mlst.ucc.ie/mlst/dbs/Ecoli) to confirm ST131 status, which was done for 12 B2-O25b isolates, 26 B2-O16 isolates, 5 putative B1-O25b and 6 O-non-typeable isolates. Isolates determined by MLST to be ST131, but that were classified into phylogenetic group B1 by phylo-PCR based on the absence of chuA, were considered to belong to phylogenetic group B2. 5 ST131 isolates were assessed for H30 status by subclone-specific PCR. 13 All H30 PCR-negative isolates, and approximately 10% of H30 PCR-positive isolates, underwent direct sequencing of fimH.
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Isolates with a fimH allele that differed by only one nucleotide (i.e. one SNP) in comparison with an established fimH allele reference sequence were considered to belong to the corresponding fimH allele group. Ciprofloxacin-non-susceptible H30 isolates were classified as H30R.
16
H30 isolates were assessed for H30Rx status by subclone-specific PCR. 14 
Susceptibility testing
Antibiotic susceptibility was evaluated by microdilution using a Dry Plate Eiken (Eiken, Tokyo, Japan). Drugs tested included ciprofloxacin, trimethoprim/sulfamethoxazole, amikacin, gentamicin, tobramycin, minocycline, ampicillin/sulbactam, piperacillin/tazobactam, imipenem and meropenem. The results were interpreted using the 2012 CLSI breakpoints. 20 Intermediate and resistant results were analysed as non-susceptible. MDR was defined as non-susceptible to at least one agent in three or more antimicrobial classes. 33 
Virulence genotypes
The presence of 29 ExPEC-associated virulence genes was evaluated by multiplex PCR. 34 Isolates were defined as ExPEC if positive for two of the following genes or gene sets: papA and/or papC (P fimbriae), sfa/focDE (S and F1C fimbriae), afa/draBC (Dr-binding adhesins), kpsM II (group 2 capsule) and iutA (aerobactin siderophore system). 29 The virulence score was the number of virulence genes detected, adjusted for multiple detection of the pap, sfa, foc and kpsM II operons. The four described virotypes of ST131 (A-D) were determined according to the presence of afa FM955459, iroN, ibeA and sat, which were detected by two sets of triplex PCR assays.
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Characterization of the genetic environment of bla CTX-M To determine the genetic structure of the regions flanking bla CTX-M , PCR mapping and direct sequencing of the flanking region amplicons Matsumura et al.
were performed with primers described in Table S1 (available as Supplementary data at JAC Online). Primer combinations and amplicon sizes are shown in Tables S2 -S4. All bla CTX-M -positive isolates underwent PCR mapping. For each identified structural variant, the genetic structure from at least one randomly selected isolate was determined by sequencing, and the nucleotide sequence was deposited in the GenBank database.
Statistical analysis
Categorical variables were compared using Fisher's exact test. Continuous variables were compared using Student's t-test and one-way analysis of variance. The yearly prevalence of isolates was analysed using the x 2 test for linear trend. A P value ,0.05 was considered statistically significant. We conducted our statistical analysis using Stata, version 11.2 (StataCorp, College Station, TX, USA).
Results and discussion
Between 2001 and 2012, a total of 1079 ESBL-gene-positive E. coli isolates were collected, of which 461 (43%) were ST131 (Table S5) . According to fimH-based subclonal typing, these comprised 398 H30 isolates, 49 H41 group isolates (H41, n ¼ 46; H89, n ¼ 2; H448, n¼ 1), 10 H22 group isolates (H22, n¼ 9; H376, n ¼ 1) and 4 other H type isolates (H27, n¼ 2; H54, n¼ 2). The 398 H30 isolates included 396 ciprofloxacin-non-susceptible H30R isolates, of which 64 (16%) represented the H30Rx subset. Figure 1 2 test for linear trend). The prevalence of ST131, H30Rx, other H30, the H41 group and non-ST131 isolates also increased yearly (each P,0.001). (b) Change in ESBL subtypes among ESBL-producing ST131 isolates. CTX-M-27 producers (P,0.001) and CTX-M-15 producers (P ¼0.008) increased yearly in prevalence, whereas CTX-M-14 producers (P, 0.001) and other CTX-M producers (P, 0.001) decreased. (c) The CTX-M-27-producing H30R (non-Rx) subclonal group, the CTX-M-15-producing H30Rx subclonal group, the CTX-M-14-producing H30R (non-Rx) subclonal group and the other ESBL-producing isolates increased yearly in prevalence (each P, 0.001) among E. coli isolates overall. Specifically, the CTX-M-14-H30R group and, to a lesser extent, the H41 group contributed to the increase in ST131 isolates in the early and mid-study period (2001 -08), and maintained their number after 2008. In contrast, the CTX-M-27-H30R and CTX-M-15-H30Rx groups contributed to the increase in ST131 isolates later on (2008-12).
CTX-M-27-and CTX-M-14-producing E. coli ST131-H30 
Other b-lactamase bla TEM-1 22 (34) 108 (32) 25 ( ST131 subclonal groups and bla CTX-M type 8 and 21% (Switzerland). 46 In addition, CTX-M-27-producing ST131 isolates have been reported in animals or environments in the UK, 47 Japan, 48 Switzerland 49 and central Europe. 50 In contrast, our Japanese non-ST131 ESBL-producing isolates (2001 -10) rarely had bla CTX-M-27 (2%), while the other two prevalent bla CTX-M types, bla CTX-M-14 and bla CTX-M-15 , were similarly prevalent among ST131 isolates (47% and 16%, respectively) and non-ST131 isolates (50% and 16%, respectively). 51 Three major CTX-M-producing ST131 subclonal groups Figure 1(c) shows that the spread of ESBL producers in our region has been driven by three major CTX-M-producing ST131 H30 subclonal groups: CTX-M-27-producing H30R (non-Rx), CTX-M-14-producing H30R (non-Rx) and CTX-M-15-producing H30Rx. Between 2001 and 2007, the CTX-M-14-H30R subgroup accounted for 46% of ST131 isolates, whereas the CTX-M-27-H30R and CTX-M-15-H30Rx subgroups accounted for ,4% of isolates each. In contrast, between 2008 and 2012, the CTX-M-27-H30R, CTX-M-14-H30R and CTX-M-15-H30Rx subgroups accounted for 45%, 24% and 15% of ST131 isolates, respectively. To date, three studies have reported the molecular epidemiology of the ESBL-producing H30Rx subclonal group, each documenting a global predominance of CTX-M-15 and H30Rx among ESBLproducing ST131 isolates. 14 -16 The Japanese H30Rx isolates resembled previously reported H30Rx isolates according to CTX-M-15 production, although their prevalence was lower than that of the two H30R-derived subclonal groups newly identified in this study.
The characteristics of the three subgroups are shown in Table 2 . The CTX-M-27-H30R group had a higher prevalence of ceftazidime non-susceptibility than the CTX-M-14-H30R group, but a lower prevalence of MDR than the other two groups. CTX-M-27 differs from CTX-M-14 by only the D240G substitution, and confers more potent resistance to ceftazidime than does CTX-M-14.
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The CTX-M-27-H30R and CTX-M-15-H30Rx groups had a higher prevalence of ExPEC status (92% and 87% versus 68%: P,0.001 and P¼ 0.006, respectively) and higher virulence scores Only one H30 isolate (H30-non-Rx) was resistant to imipenem, but did not possess any carbapenemases. a The H41 group included H41 (n¼46), H89 (n¼2) and H448 (n¼1), the H22 group included H22 (n ¼9) and H376 (n¼1), and other H types included H27 (n¼2) and H54 (n ¼2).
b
Values are shown where P is ,0.05; for all other comparisons, the differences were not significant. 
Genetic environment of bla CTX-M
The genetic environments of bla CTX-M in the ST131 isolates are summarized in Table 3 , and presented schematically in Figures 2 and S1. Detailed PCR mapping results are shown in Table S2 (bla CTX-M-9 group), Table S3 (bla CTX-M-1 group) and Table S4 (bla CTX-M-2 group). The genetic diversity within the bla CTX-M flanking regions corresponded to the subclonal group. That is, although ISEcp1 was almost always found upstream of bla CTX-M in the three major H30 groups, and IS903 was almost always found downstream in the CTX-M-27-H30R and CTX-M-14-H30R groups, IS26-DISEcp1 was common in the CTX-M-27-H30R group (99%), less frequent in the CTX-M-15-H30Rx group (38%) and uncommon in the CTX-M-14-H30R group (3%).
Almost all of the CTX-M-27-H30R subgroup had an IS26-DISEcp1-bla CTX-M-27 -DIS903D-IS26-like structure, with variation in the length of DIS903D (schema 9a1 -9a4). In contrast, 97% of the CTX-M-14-H30R subgroup had an ISEcp1-bla CTX-M-14 -IS903D-like structure, with variation in the length of ISEcp1 and/or IS903D (9d1 -9d4), as previously found in small-scale studies. 19, 53, 54 The bla CTX-M-27 gene differed from bla CTX-M-14 by only one nucleotide, 52 but here the surrounding genetic structures were clearly different in terms of their association with IS26. The CTX-M-27-H30R subgroup also had distinctive antibiotic resistance profiles and virulence profiles, which suggests that it is not derived from the CTX-M-14-H30R subgroup by a simple point mutation in bla CTX-M-14 . We speculate that, analogous to the H30Rx group, the CTX-M-27-H30R and CTX-M-14-H30R isolates may represent distinct phylogenetic subgroups within H30R. Future whole-genome analysis is needed to test this hypothesis. Values are shown where P is ,0.05; for all other comparisons, the differences were not significant.
Matsumura et al. 
H30Rx
(n ¼ 64)
a The H41 group included H41 (n¼41), H89 (n¼2) and H448 (n¼1), the H22 group included H22 (n ¼7) and H376 (n¼1), and the other H group included H27 (n¼2) and H54 (n¼2). b Novel sequence found in this study (no identical sequence deposited in GenBank CTX-M-27-and CTX-M-14-producing E. coli ST131-H30
plasmid of the UK epidemic strain A. 55 These observations indicate that the CTX-M-15-H30Rx subclonal group was imported into Japan and disseminated successfully there.
Virotype C predominated within the CTX-M-27-H30R and CTX-M-14-H30R subgroups (Table 2 ). This corresponds to the finding from the initial Spanish study that classified ST131 isolates into virotypes that H30 isolates producing CTX-M variants other than CTX-M-15 had virotype C. 11 Likewise, a predominance of virotype C was observed in a global collection of H30 (non-Rx) isolates. 15 Virotype C also predominated among our H30Rx isolates, which supports the results reported by Peirano et al.;
15 their global collection of 181 H30Rx isolates had virotype C (71%) or virotype A (29%). Virotype A was present in 11% of our H30Rx isolates, but most of them had a pEK499-like bla CTX-M-15 -associated structure (1c), which was also present in Spanish H30 virotype A isolates. 11 The commonality of the ESBL elements and virotypes between the international and Japanese CTX-M-14-H30R and CTX-M-15-H30Rx isolates supports that these isolates belonged to the same subclonal group.
The basis for the observed epidemic emergence of the CTX-M-27-H30R subgroup remains unclear. Postulated explanations for the success of ST131 as a whole include higher transmissibility, a greater ability to colonize in the intestine or urinary tract, enhanced virulence and MDR status. 58 In this regard, increased colonization ability or antibiotic pressure from ceftazidime use might play important fitness roles for CTX-M-27-H30R. Indeed, a higher nosocomial transmission rate of CTX-M-27-producing ST131 compared with CTX-M-15-producing ST131 was observed on rehabilitation wards. 43 This study has several limitations. The bla CTX-M genetic environment was confirmed by sequencing for only a subset of ST131 isolates and no non-ST131 isolates. However, we used a PCR mapping approach to type all of the ST131 isolates in this large collection. Additionally, the isolates were collected regionally, not nationwide, possibly limiting generalizability. Similar analyses of isolates from other parts of Japan, other Asian countries and other continents are needed.
Conclusions
To our knowledge this is the first study to elucidate the relationships between ST131 subclonal groups and bla CTX-M mobile elements, and to define temporal prevalence trends for ST131 subclonal groups and their associated CTX-M variants in Japan. We identified two distinct ST131 subclonal groups, CTX-M-14-H30R and CTX-M-27-H30R, the latter having recently expanded in the Kyoto -Shiga region of Japan and being associated with the IS26, ISEcp1 and IS903D mobile elements. These subgroups may already have disseminated worldwide in clinical settings, animals and the environment, and may be becoming prevalent in some countries; surveillance for them is needed. The CTX-15-H30Rx subclonal group, with the same bla CTX-M-15 genetic elements as described in other parts of the world, was newly detected in Japan, extending the known global extent of this ST131 subclone. Further analysis and understanding of the distinct CTX-M-27-producing H30R, CTX-M-14-producing H30R and CTX-M-15-producing H30Rx subclonal groups will provide important knowledge to control the increase in ESBL producers.
